Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Study to Assess Brain Uptake and Safety of AH110690 (18F) Injection in Subjects with Probable
Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers.
Phase:
Phase 2
Details
Lead Sponsor:
GE Healthcare
Collaborators:
Hvidovre Hospital Center Demark Danish Research Centre for Magnetic Resonance Hvidovre University Hospital i3 Statprobe Medpace, Inc.